Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20091
20113
20134
20141
20181
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bayer2
Seoul National University Bundang Hospital2
CSL Behring1
Dong-A University1
Janssen Research & Development, LLC1
Keimyung University Dongsan Medical Center1
NYU Langone Health1
Novartis Pharmaceuticals1
Seung-Jung Park1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease14
Acute Coronary Syndrome3
Heart Failure3
Myocardial Infarction3
Stroke3
Diabetes Mellitus2
Heart Diseases2
Peripheral Arterial Disease2
Angina Pectoris1
Angina, Unstable1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.